This workshop will consider new strategies to identify developmental hazards taking into account the current state of science which may include alternative possibilities or improvements to the current Segment 2 design. These considerations could include the use of new technology to overcome some of the limitations in predicting human response with current animal models or completely new radical approach to developmental toxicity hazard identification. These may range from having a critical paradigm to deciding when non-clinical studies are needed to the use of biotechnology and computational models or hazard characterization. Working groups can consider either strategy, or combinations of the two. This event is HESI Future Leaders Travel Award (FLT) eligible!
The field of immunotoxicology is a dynamic one in which changing public health concerns, novel biomedical research advances, and innovative technological developments constantly change the landscape and the way in which work is carried out and utilized. As this field requires combined expertise in both immunology and toxicology, the need for continued training and interdisciplinary interactions are critical for those who work within this field. This is essential both for those with an immunology background who seek to apply this expertise to drug development and safety, as well as those who wish to enhance their current drug safety expertise with a deeper understanding of immunology. This event is HESI Future Leaders Travel Award (FLT) eligible!
Don’t miss these great HESI presentations and events featuring HESI members and committee science at the 2017 SOT Annual Meeting in Baltimore, MD.
The need to develop new tools and increased capacity to test chemicals and pharmaceuticals for potential adverse impact on human health and the environment is an active area of development. A series of NRC reports in 2007 and 2009 recognized and recommended that effective implementation of new technologies in risk assessment requires interdisciplinary and inter-sector dialogue, as well as a consistent and coherent strategy for validating and then integrating new technologies into the existing risk assessment framework.
This training will feature a presentation of the RISK21 approach and application of the RISK21 Webtool.